Frauke Goeman

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Epithelial Mesenchymal Transition

Transcription Factor

Top Venues

Cell death discovery

Cell death & disease

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Stefano Scalera, Biagio Ricciuti, Daniele Marinelli, Marco Mazzotta, Laura Cipriani, Giulia Bon, Giulia Schiavoni, Irene Terrenato, Alessandro Di Federico, Joao M Victor Alessi, Maurizio Fanciulli, Ludovica Ciuffreda, Francesca De Nicola, Frauke Goeman, Giulio Caravagna, Daniele Santini, Ruggero De Maria, Federico Cappuzzo, Gennaro Ciliberto, Mariam Jamal-Hanjani, Mark M Awad, Nicholas McGranahan, Marcello Maugeri-Saccà
Transcriptional phenocopies of deleterious KEAP1 mutations correlate with survival outcomes in lung cancer treated with immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Martina Dragonetti, Chiara Turco, Anna Benedetti, Frauke Goeman, Mattia Forcato, Stefano Scalera, Matteo Allegretti, Gabriella Esposito, Francesco Fazi, Giovanni Blandino, Sara Donzelli, Giulia Fontemaggi
The lncRNAMALAT1-WTAP axis: a novel layer of EMT regulation in hypoxic triple-negative breast cancer. Cell death discovery 10 (1) (2024)
Valeria Canu, Sebastiano Vaccarella, Andrea Sacconi, Claudio Pulito, Frauke Goeman, Matteo Pallocca, Daniela Rutigliano, Sima Lev, Sabrina Strano, Giovanni Blandino
Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancer. Cell death & disease 15 (8) (2024)
Martina Dragonetti, Chiara Turco, Anna Benedetti, Frauke Goeman, Mattia Forcato, Stefano Scalera, Matteo Allegretti, Gabriella Esposito, Francesco Fazi, Giovanni Blandino, Sara Donzelli, Giulia Fontemaggi
The lncRNAMALAT1-WTAP axis: a novel layer of EMT regulation in hypoxic triple-negative breast cancer. Cell death discovery 10 (1) (2024)
Valeria Canu, Sebastiano Vaccarella, Andrea Sacconi, Claudio Pulito, Frauke Goeman, Matteo Pallocca, Daniela Rutigliano, Sima Lev, Sabrina Strano, Giovanni Blandino
Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancer. Cell death & disease 15 (8) (2024)
Martina Dragonetti, Chiara Turco, Anna Benedetti, Frauke Goeman, Mattia Forcato, Stefano Scalera, Matteo Allegretti, Gabriella Esposito, Francesco Fazi, Giovanni Blandino, Sara Donzelli, Giulia Fontemaggi
The lncRNAMALAT1-WTAP axis: a novel layer of EMT regulation in hypoxic triple-negative breast cancer. Cell death discovery 10 (1) (2024)
Andrea Sacconi, Claudia De Vitis, Luisa de Latouliere, Simona di Martino, Francesca De Nicola, Frauke Goeman, Carla Mottini, Francesca Paolini, Michela D'Ascanio, Alberto Ricci, Agostino Tafuri, Paolo Marchetti, Arianna Di Napoli, Luciano De Biase, Andrea Negro, Christian Napoli, Paolo Anibaldi, Valentina Salvati, Darragh Duffy, Benjamin Terrier, Maurizio Fanciulli, Carlo Capalbo, Salvatore Sciacchitano, Giovanni Blandino, Giulia Piaggio, Rita Mancini, Gennaro Ciliberto
Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients. Cell death & disease 12 (11) (2021)